Paper37129253
Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine.
Overchuk M and 3 others. ACS Nano, 2023. Cited by 826 papers, by iCite.
Cite this record
ConductScience Library. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. Papers, record 37129253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37129253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Photochemotherapy | Major topic |
| Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Photosensitizing Agents | |
| Photothermal Therapy | |
| Nanomedicine | |
| Phototherapy | |
| Cell Line, Tumor |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FDN154326 | CIHR | Canada | PubMed |
Source PubMed
References220
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27543602 | An Integrated Nanotechnology-Enabled Transbronchial Image-Guided Intervention Strategy for Peripheral Lung Cancer. | Cancer Res | 2016 | https://conductscience.org/library/papers/27543602 | PubMed |
| 2 | 33986437 | Hyperthermia by near infrared radiation induced immune cells activation and infiltration in breast tumor. | Sci Rep | 2021 | https://conductscience.org/library/papers/33986437 | PubMed |
| 3 | 33729683 | Transcriptomic analysis of mechanism of melanoma cell death induced by photothermal therapy. | J Biophotonics | 2021 | https://conductscience.org/library/papers/33729683 | PubMed |
| 4 | 6234913 | Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6234913 | PubMed |
| 5 | 8763884 | Tumour pO2 can be increased markedly by mild hyperthermia. | Br J Cancer Suppl | 1996 | https://conductscience.org/library/papers/8763884 | PubMed |
| 6 | 32271563 | Reprogramming Tumor Microenvironment with Photothermal Therapy. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/32271563 | PubMed |
| 7 | 12630747 | Models and measurements of light intensity changes during laser interstitial thermal therapy: implications for optical monitoring of the coagulation boundary location. | Phys Med Biol | 2003 | https://conductscience.org/library/papers/12630747 | PubMed |
| 8 | 30713637 | Penetration depth tunable BODIPY derivatives for pH triggered enhanced photothermal/photodynamic synergistic therapy. | Chem Sci | 2019 | https://conductscience.org/library/papers/30713637 | PubMed |
| 9 | 9077123 | The role of subcellular localization in initiation of apoptosis by photodynamic therapy. | Photochem Photobiol | 1997 | https://conductscience.org/library/papers/9077123 | PubMed |
| 10 | 19424466 | Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. | Can Urol Assoc J | 2009 | https://conductscience.org/library/papers/19424466 | PubMed |
| 11 | 33147800 | Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/33147800 | PubMed |
| 12 | 31518145 | Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia? | Nano Lett | 2019 | https://conductscience.org/library/papers/31518145 | PubMed |
| 13 | 36442438 | Repeated photodynamic therapy mediates the abscopal effect through multiple innate and adaptive immune responses with and without immune checkpoint therapy. | Biomaterials | 2023 | https://conductscience.org/library/papers/36442438 | PubMed |
| 14 | 34965307 | Methods of monitoring thermal ablation of soft tissue tumors - A comprehensive review. | Med Phys | 2022 | https://conductscience.org/library/papers/34965307 | PubMed |
| 15 | 29048439 | Advancing porphyrin's biomedical utility via supramolecular chemistry. | Chem Soc Rev | 2017 | https://conductscience.org/library/papers/29048439 | PubMed |
| 16 | 29527710 | Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent. | Lasers Surg Med | 2018 | https://conductscience.org/library/papers/29527710 | PubMed |
| 17 | 10378010 | Enhancement of ALA-PDT damage by IR-induced hyperthermia on a colon carcinoma model. | Photochem Photobiol | 1999 | https://conductscience.org/library/papers/10378010 | PubMed |
| 18 | 32343868 | Precisely Tuning Photothermal and Photodynamic Effects of Polymeric Nanoparticles by Controlled Copolymerization. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/32343868 | PubMed |
| 19 | 34936918 | Recent advances and trends in nanoparticles based photothermal and photodynamic therapy. | Photodiagnosis Photodyn Ther | 2022 | https://conductscience.org/library/papers/34936918 | PubMed |
| 20 | 30834048 | Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. | World J Oncol | 2019 | https://conductscience.org/library/papers/30834048 | PubMed |
Cited by385
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 826 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985092 | Illuminating metabolic disorders with engineered fluorescent carbon dots: advances in biosensing to therapeutics. | RSC Adv | 2026 | https://conductscience.org/library/papers/42985092 | PubMed |
| 42978988 | Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42978988 | PubMed |
| 42891370 | Osteosarcoma Nanomedicine: From Resistance Reversal to Bone Reconstruction. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42891370 | PubMed |
| 42883253 | Porphyrin-Based Compounds in Medicine: From Photodynamic Therapy to Theranostics. | Molecules | 2026 | https://conductscience.org/library/papers/42883253 | PubMed |
| 42882510 | Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy. | Cells | 2026 | https://conductscience.org/library/papers/42882510 | PubMed |
| 42864757 | Near-Infrared Triggered Rechargeable Singlet Oxygen Battery for Sustained Phototherapy: Fast Charging and Long-Lasting Discharging. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42864757 | PubMed |
| 42848277 | Ablation-immunotherapy synergy in cancer: mechanisms of the abscopal effect, emerging clinical applications, and translational roadmaps for next-generation onco-immunology. | Med Oncol | 2026 | https://conductscience.org/library/papers/42848277 | PubMed |
| 42835614 | Contractile hydrogel with NIR-induced spatiotemporally programmed release from core-shell nanoparticles for integrated antibacterial and pro-angiogenic healing. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42835614 | PubMed |
| 42798764 | Current advances in metal nanoparticle-based stimuli-responsive nanotherapies. | Front Chem | 2026 | https://conductscience.org/library/papers/42798764 | PubMed |
| 42796510 | Reprogramming Photodynamic Therapy with BODIPY Photosensitizers: From Local Phototoxicity Toward Precision Photodynamic Oncology. | Molecules | 2026 | https://conductscience.org/library/papers/42796510 | PubMed |
| 42792772 | Demystifying Nanotherapeutic Modalities: Unravelling the Mysteries from Antibiofilm Mechanisms to Regenerative and Clinical Translation. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792772 | PubMed |
| 42792633 | Photodynamic Therapy in Cancer: Mechanisms, Photosensitizer Technology, Vitamin Modulation, and Rational Combination Design. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792633 | PubMed |
| 42791476 | Dual-Mode Fluorescence/UV-Vis Sensing Platform Based on Luminescence Modulation of Upconversion Nanoparticles. | J Fluoresc | 2026 | https://conductscience.org/library/papers/42791476 | PubMed |
| 42780581 | NLS-functionalized semiconducting polymer nanoparticles for enhanced intracellular accumulation and combined photodynamic-photothermal cancer therapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/42780581 | PubMed |
| 42771301 | 2D nanomaterials for near infrared responsive photomedicine: a review. | Nano Converg | 2026 | https://conductscience.org/library/papers/42771301 | PubMed |
| 42737753 | Linking In Vivo Imaging to Therapeutic Outcome with 131I, 177Lu, 188Re Nanoparticles. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737753 | PubMed |
| 42668618 | Porphyrin-copper (II) covalent organic framework nanoplatform with intrinsic bifunctional photodynamic and chemodynamic activities for synergistic multimodal cancer therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42668618 | PubMed |
| 42653467 | Context-Dependent Mechanisms of Oncologic Photodynamic Therapy: A Framework Linking Treatment Parameters to Cellular, Vascular, and Immune Responses. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653467 | PubMed |
| 42626281 | In Vitro Evaluation of Silica-Coated Bi2Se3 Nanoplatelets as Photothermal Nanomaterials. | ACS Omega | 2026 | https://conductscience.org/library/papers/42626281 | PubMed |
| 42602257 | Magnetically Navigated and PSMA/STEAP1 Dual-Targeted Nanoliposomes for NIR-II/MRI Imaging with Photothermal-Chemo-Immunotherapy for Prostate Cancer. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42602257 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37129253
GET https://conductscience.org/api/papers/v1/37129253/references?page=2